LUNG ADENOCARCINOMA METASTATIC
Clinical trials for LUNG ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new LUNG ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for LUNG ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to personalize lung cancer treatment
Disease control Recruiting nowThis study is for people with a specific type of advanced lung cancer (EGFR L858R mutation). It tests a treatment plan that starts with a targeted drug (aumolertinib) alone for 6 weeks, then adds chemotherapy for 4 cycles, and finally continues with the targeted drug alone. The g…
Matched conditions: LUNG ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Taipei Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug CT-95 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called CT-95 in people with advanced cancers that have a protein called mesothelin on their cells. The main goals are to find a safe dose and see if the drug can shrink tumors. About 70 adults with ovarian, lung, pancreatic, or other mesoth…
Matched conditions: LUNG ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Yoga and mindfulness may help cancer survivors heal from within
Symptom relief Recruiting nowThis study tests whether yoga and mindfulness programs can improve quality of life, reduce inflammation, and even affect gene activity in people who have survived lung, colon, or non-Hodgkin's lymphoma cancer. One hundred survivors, at least six months past treatment, will be ran…
Matched conditions: LUNG ADENOCARCINOMA METASTATIC
Phase: NA • Sponsor: Barbara Nemesure • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC